Serotonin and Depression: What We Actually Know

No, depression is not just "low serotonin." That explanation, repeated for decades in ads and pamphlets, is an oversimplification of a much messier picture. Serotonin is involved in mood regulation, but decades of research have not produced consistent evidence that depression is caused by low serotonin levels or serotonin activity on its own. That finding does not mean antidepressants don't work — large numbers of people get real relief from SSRIs — it means the reason they work is more complicated than a simple chemical shortage. This article explains what current research actually supports, why the serotonin story stuck around anyway, and what it means for how depression gets treated.

Where did the "low serotonin" explanation come from?

The serotonin hypothesis dates to the 1960s, when researchers noticed that drugs affecting serotonin levels also affected mood. Pharmaceutical marketing in the 1990s simplified this into a public-facing story: depression is caused by a chemical imbalance, and SSRIs correct it. It was an easy story to tell and it reduced stigma by framing depression as biological rather than a personal failing. The problem is that decades of follow-up research never found the direct, simple cause-and-effect the marketing implied.

What does the research actually show?

Modern research points to depression as a condition shaped by multiple interacting systems rather than one neurotransmitter running low. Genetics, chronic stress exposure, inflammation, sleep disruption, and life circumstances all appear to contribute. The National Institute of Mental Health describes depression as involving a combination of genetic, biological, environmental, and psychological factors — not a single chemical deficiency. Serotonin, dopamine, and norepinephrine all interact with mood circuits in the brain, and no single one has been isolated as "the" cause.

If serotonin isn't the whole story, why do SSRIs work?

SSRIs (selective serotonin reuptake inhibitors) do change how serotonin is used in the brain, and for many people that change is followed by measurable improvement in depressive symptoms. What's uncertain is the mechanism connecting the two. Leading theories now focus less on raising serotonin levels and more on how SSRIs may support neuroplasticity — the brain's ability to form and strengthen connections — over weeks of use, which lines up with why antidepressants typically take several weeks to show full effect rather than working immediately. For more on how the brain changes with treatment, see our article on neuroplasticity and recovery.

Does this mean medication doesn't matter?

No. Clinical trial data consistently shows SSRIs and other antidepressants outperform placebo for moderate to severe depression, and many people describe them as genuinely life-changing. What the serotonin-hypothesis debate changes is the explanation, not the outcome data. It also argues against treating medication as a stand-alone fix: because depression involves multiple systems, the most consistent results come from pairing medication management with therapy that addresses thought patterns, coping skills, and life stressors — see our overview of cognitive behavioral therapy.

How is depression actually diagnosed and treated?

A depression diagnosis starts with a clinical evaluation, often supported by a screening tool like the PHQ-9, but a score alone is not a diagnosis — a clinician interprets it alongside your history and symptoms. From there, treatment is matched to severity and your life circumstances. At Golden Coast, our partial hospitalization program and intensive outpatient program both combine psychiatric medication management with structured therapy for people whose depression needs more support than weekly counseling alone. We treat depression as one of the core conditions in our mental health track, and depression frequently overlaps with anxiety, trauma, or substance use — our page on co-occurring disorders covers how that's assessed.